Pulmonary metastasectomy from soft tissue sarcomas

INTRODUCTION: Isolated pulmonary metastases from soft tissue sarcomas occur in 20-50% of these(the issue is about metastases, not lung cancer )patients, and 70% of these patients will present disease limited only to the lungs. Surgical resection is well accepted as a standard approach to treat metastases from soft tissue sarcomas isolated in the lungs, and many studies investigating this technique have reported an overall 5-year survival ranging from 30-40%. The most consistent predictor of survival in these patients is complete resection. The aim of the present study was to determine the demographics and clinical treatment-related variables associated with long-term (90-month) overall survival in patients with lung metastases undergoing pulmonary metastasectomy from soft tissue sarcomas. METHODS: We performed a retrospective review of patients admitted in the Thoracic Surgery Department with lung metastases who underwent thoracotomy for resection following treatment of the primary tumor. Data regarding primary tumor features, demographics, treatment, and outcome were collected. RESULTS: One hundred twenty-two thoracotomies and 273 nodules were resected from 77 patients with previously treated soft tissue sarcomas. The median follow-up time of all patients was 36.7 months (range: 10-138 months). The postoperative complication rate was 9.1%, and the 30-day mortality rate was 0%. The 90-month overall survival rate for all patients was 34.7%. Multivariate analysis identified the following independent prognostic factors for overall survival: the number of metastases resected, the disease-free interval, and the number of complete resections. CONCLUSION: These results confirm that lung metastasectomy is a safe and potentially curative procedure for patients with treated primary tumors. A select group of patients can achieve long-term survival after lung resection.

Saved in:
Bibliographic Details
Main Authors: Sardenberg,Rodrigo Afonso da Silva, Figueiredo,Luiz Poli de, Haddad,Fábio José, Gross,Jefferson Luiz, Younes,Riad Naim
Format: Digital revista
Language:English
Published: Faculdade de Medicina / USP 2010
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322010000900010
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1807-59322010000900010
record_format ojs
spelling oai:scielo:S1807-593220100009000102010-10-22Pulmonary metastasectomy from soft tissue sarcomasSardenberg,Rodrigo Afonso da SilvaFigueiredo,Luiz Poli deHaddad,Fábio JoséGross,Jefferson LuizYounes,Riad Naim Lung Metastases Soft tissue sarcomas Metastasectomy Prognostic factors INTRODUCTION: Isolated pulmonary metastases from soft tissue sarcomas occur in 20-50% of these(the issue is about metastases, not lung cancer )patients, and 70% of these patients will present disease limited only to the lungs. Surgical resection is well accepted as a standard approach to treat metastases from soft tissue sarcomas isolated in the lungs, and many studies investigating this technique have reported an overall 5-year survival ranging from 30-40%. The most consistent predictor of survival in these patients is complete resection. The aim of the present study was to determine the demographics and clinical treatment-related variables associated with long-term (90-month) overall survival in patients with lung metastases undergoing pulmonary metastasectomy from soft tissue sarcomas. METHODS: We performed a retrospective review of patients admitted in the Thoracic Surgery Department with lung metastases who underwent thoracotomy for resection following treatment of the primary tumor. Data regarding primary tumor features, demographics, treatment, and outcome were collected. RESULTS: One hundred twenty-two thoracotomies and 273 nodules were resected from 77 patients with previously treated soft tissue sarcomas. The median follow-up time of all patients was 36.7 months (range: 10-138 months). The postoperative complication rate was 9.1%, and the 30-day mortality rate was 0%. The 90-month overall survival rate for all patients was 34.7%. Multivariate analysis identified the following independent prognostic factors for overall survival: the number of metastases resected, the disease-free interval, and the number of complete resections. CONCLUSION: These results confirm that lung metastasectomy is a safe and potentially curative procedure for patients with treated primary tumors. A select group of patients can achieve long-term survival after lung resection.info:eu-repo/semantics/openAccessFaculdade de Medicina / USPClinics v.65 n.9 20102010-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322010000900010en10.1590/S1807-59322010000900010
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Sardenberg,Rodrigo Afonso da Silva
Figueiredo,Luiz Poli de
Haddad,Fábio José
Gross,Jefferson Luiz
Younes,Riad Naim
spellingShingle Sardenberg,Rodrigo Afonso da Silva
Figueiredo,Luiz Poli de
Haddad,Fábio José
Gross,Jefferson Luiz
Younes,Riad Naim
Pulmonary metastasectomy from soft tissue sarcomas
author_facet Sardenberg,Rodrigo Afonso da Silva
Figueiredo,Luiz Poli de
Haddad,Fábio José
Gross,Jefferson Luiz
Younes,Riad Naim
author_sort Sardenberg,Rodrigo Afonso da Silva
title Pulmonary metastasectomy from soft tissue sarcomas
title_short Pulmonary metastasectomy from soft tissue sarcomas
title_full Pulmonary metastasectomy from soft tissue sarcomas
title_fullStr Pulmonary metastasectomy from soft tissue sarcomas
title_full_unstemmed Pulmonary metastasectomy from soft tissue sarcomas
title_sort pulmonary metastasectomy from soft tissue sarcomas
description INTRODUCTION: Isolated pulmonary metastases from soft tissue sarcomas occur in 20-50% of these(the issue is about metastases, not lung cancer )patients, and 70% of these patients will present disease limited only to the lungs. Surgical resection is well accepted as a standard approach to treat metastases from soft tissue sarcomas isolated in the lungs, and many studies investigating this technique have reported an overall 5-year survival ranging from 30-40%. The most consistent predictor of survival in these patients is complete resection. The aim of the present study was to determine the demographics and clinical treatment-related variables associated with long-term (90-month) overall survival in patients with lung metastases undergoing pulmonary metastasectomy from soft tissue sarcomas. METHODS: We performed a retrospective review of patients admitted in the Thoracic Surgery Department with lung metastases who underwent thoracotomy for resection following treatment of the primary tumor. Data regarding primary tumor features, demographics, treatment, and outcome were collected. RESULTS: One hundred twenty-two thoracotomies and 273 nodules were resected from 77 patients with previously treated soft tissue sarcomas. The median follow-up time of all patients was 36.7 months (range: 10-138 months). The postoperative complication rate was 9.1%, and the 30-day mortality rate was 0%. The 90-month overall survival rate for all patients was 34.7%. Multivariate analysis identified the following independent prognostic factors for overall survival: the number of metastases resected, the disease-free interval, and the number of complete resections. CONCLUSION: These results confirm that lung metastasectomy is a safe and potentially curative procedure for patients with treated primary tumors. A select group of patients can achieve long-term survival after lung resection.
publisher Faculdade de Medicina / USP
publishDate 2010
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322010000900010
work_keys_str_mv AT sardenbergrodrigoafonsodasilva pulmonarymetastasectomyfromsofttissuesarcomas
AT figueiredoluizpolide pulmonarymetastasectomyfromsofttissuesarcomas
AT haddadfabiojose pulmonarymetastasectomyfromsofttissuesarcomas
AT grossjeffersonluiz pulmonarymetastasectomyfromsofttissuesarcomas
AT younesriadnaim pulmonarymetastasectomyfromsofttissuesarcomas
_version_ 1756432081700782080